Attached files

file filename
EX-32.1 - CERTIFICATION - Ocata Therapeutics, Inc.ocata_10q-ex3201.htm
EX-31.1 - CERTIFICATION - Ocata Therapeutics, Inc.ocata_10q-ex3101.htm
EX-31.2 - CERTIFICATION - Ocata Therapeutics, Inc.ocata_10q-ex3102.htm
10-Q - QUARTERLY REPORT - Ocata Therapeutics, Inc.ocata_10q-093015.htm

EXHIBIT 32.2

 

CERTIFICATIONS OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Edward Myles, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Ocata Therapeutics, Inc. for the quarter ended September 30, 2015 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Ocata Therapeutics, Inc.

 

     
Dated: November 9, 2015 By: /s/ Edward Myles
    Edward Myles
    Principal Financial Officer